[1] |
Bastuji⁃Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity⁃of⁃illness score for toxic epidermal necrolysis[J]. J Invest Dermatol, 2000,115(2):149⁃153. doi: 10.1046/j.1523⁃1747.2000.00061.x.
|
[2] |
Cartotto R, Mayich M, Nickerson D, et al. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center[J]. J Burn Care Res, 2008,29(1):141⁃146. doi: 10.1097/BCR.0b013e31815f3865.
|
[3] |
Wambier CG, Hoekstra TA, Wambier S, et al. Epidermal necrolysis: SCORTEN performance in AIDS and non⁃AIDS patients[J]. An Bras Dermatol, 2019,94(1):17⁃23. doi: 10.1590/abd1806⁃4841.20196864.
|
[4] |
王昱璐, 左亚刚, 刘洁, 等. SCORTEN评分对中毒性表皮坏死松解症和Stevens⁃Johnson综合征评估分析[J]. 中华皮肤科杂志, 2016,49(9):651⁃653. doi: 10.3760/cma.j.issn.0412⁃4030. 2016.09.011.
|
[5] |
中华医学会皮肤性病学分会药物不良反应研究中心. Stevens⁃Johnson综合征/中毒性表皮坏死松解症诊疗专家共识[J]. 中华皮肤科杂志, 2021,54(5):376⁃381. doi: 10.35541/cjd.2020 1177.
|
[6] |
Zavala S, O′Mahony M, Mahony M, et al. How does SCORTEN score?[J]. J Burn Care Res, 2018,39(4):555⁃561. doi: 10.1093/jbcr/irx016.
|
[7] |
Torres⁃Navarro I, Briz⁃Redón Á, Botella⁃Estrada R. Accuracy of SCORTEN to predict the prognosis of Stevens⁃Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta⁃analysis[J]. J Eur Acad Dermatol Venereol, 2020,34(9):2066⁃2077. doi: 10.1111/jdv.16137.
|
[8] |
Zhang AJ, Nygaard RM, Endorf FW, et al. Stevens⁃Johnson syndrome and toxic epidermal necrolysis: retrospective review of 10⁃year experience[J]. Int J Dermatol, 2019,58(9):1069⁃1077. doi: 10.1111/ijd.14409.
|
[9] |
Noe MH, Rosenbach M, Hubbard RA,et al. Development and validation of a risk prediction model for in⁃hospital mortality among patients with Stevens⁃Johnson syndrome/toxic epidermal necrolysis⁃ABCD⁃10[J]. JAMA Dermatol, 2019,155(4):448⁃454. doi: 10.1001/jamadermatol.2018.5605.
|
[10] |
Bastuji⁃Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens⁃Johnson syndrome, and erythema multiforme[J]. Arch Dermatol, 1993,129(1):92⁃96.
|
[11] |
Deng Q, Fang X, Zeng Q, et al. Severe cutaneous adverse drug reactions of Chinese inpatients: a meta⁃analysis[J]. An Bras Dermatol, 2017,92(3):345⁃349. doi: 10.1590/abd1806⁃4841. 20175171.
|
[12] |
Carrasquillo OY, Santiago⁃Vazquez M, Cardona R, et al. Stevens⁃Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study[J]. Int J Dermatol, 2019,58(11):1293⁃1299. doi: 10.1111/ijd.14493.
|
[13] |
Yang L, Shou YH, Li F, et al. Retrospective study of 213 cases of Stevens⁃Johnson syndrome and toxic epidermal necrolysis from China[J]. Burns, 2020,46(4):959⁃969. doi: 10.1016/j.burns. 2019.10.008.
|
[14] |
Watanabe T, Go H, Saigusa Y, et al. Mortality and risk factors on admission in toxic epidermal necrolysis: a cohort study of 59 patients[J]. Allergol Int, 2021,70(2):229⁃234. doi: 10.1016/j.alit.2020.11.004.
|
[15] |
Hu CH, Chang NJ, Liu EK, et al. SCORTEN and impaired renal function related to mortality of toxic epidermal necrolysis syndrome patients in the Asian population[J]. J Eur Acad Dermatol Venereol, 2013,27(5):628⁃633. doi: 10.1111/j.1468⁃3083.2012.04502.x.
|
[16] |
Yang MS, Lee JY, Kim J, et al. Incidence of Stevens⁃Johnson syndrome and toxic epidermal necrolysis: a nationwide population⁃based study using national health insurance database in Korea[J/OL]. PLoS One, 2016,11(11):e0165933. doi: 10. 1371/journal.pone.0165933.
|
[17] |
Tuchinda P, Chularojanamontri L, Sukakul T, et al. Cutaneous adverse drug reactions in the elderly: a retrospective analysis in Thailand[J]. Drugs Aging, 2014,31(11):815⁃824. doi: 10.1007/s40266⁃014⁃0209⁃x.
|
[18] |
Frey N, Jossi J, Bodmer M, et al. The epidemiology of Stevens⁃Johnson syndrome and toxic epidermal necrolysis in the UK[J]. J Invest Dermatol, 2017,137(6):1240⁃1247. doi: 10.1016/j.jid.2017.01.031.
|
[19] |
Hsu DY, Brieva J, Silverberg NB, et al. Morbidity and mortality of Stevens⁃Johnson syndrome and toxic epidermal necrolysis in United States adults[J]. J Invest Dermatol, 2016,136(7):1387⁃1397. doi: 10.1016/j.jid.2016.03.023.
|
[20] |
Bettuzzi T, Penso L, de Prost N, et al. Trends in mortality rates for Stevens⁃Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017[J]. Br J Dermatol, 2020,182(1):247⁃248. doi: 10.1111/bjd. 18360.
|
[21] |
Koh HK, Fook⁃Chong S, Lee HY. Assessment and comparison of performance of ABCD⁃10 and SCORTEN in prognostication of epidermal necrolysis[J]. JAMA Dermatol, 2020,156(12):1294⁃1299. doi: 10.1001/jamadermatol.2020.3654.
|
[22] |
Shou Y, Yang L, Yang Y, et al. Cohort study of patients with Stevens⁃Johnson syndrome and toxic epidermal necrolysis in China: evaluation of risk models and new predictor of pulmonary consolidation on computed tomography[J]. Front Med, 2021,15(4):585⁃593. doi: 10.1007/s11684⁃020⁃0817⁃2.
|
[23] |
Duplisea MJ, Roberson ML, Chrisco L, et al. Performance of ABCD⁃10 and SCORTEN mortality prediction models in a cohort of patients with Stevens⁃Johnson syndrome/toxic epidermal necrolysis[J]. J Am Acad Dermatol, 2021,85(4):873⁃877. doi: 10.1016/j.jaad.2021.04.082.
|